Michael P. Dube - VP, Chief Accounting Officer at Intellia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
VP, Chief Accounting Officer
Stock Symbol
NTLA on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
All Insider Reports
All Insider Reports

Michael P. Dube - trading volume in the past year for Intellia Therapeutics, Inc.

Holdings reported by Michael P. Dube for Intellia Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 47K $894K $19.01 Oct 2, 2024 Direct

Transactions reported by Michael P. Dube for Intellia Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.